Royal Bank of Canada’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-19,676
Closed -$119K 6559
2019
Q4
$119K Buy
19,676
+11,376
+137% +$68.8K ﹤0.01% 4414
2019
Q3
$30K Buy
8,300
+800
+11% +$2.89K ﹤0.01% 4740
2019
Q2
$20K Sell
7,500
-5,009
-40% -$13.4K ﹤0.01% 4965
2019
Q1
$37K Buy
12,509
+10,009
+400% +$29.6K ﹤0.01% 4643
2018
Q4
$4K Sell
2,500
-3,615
-59% -$5.78K ﹤0.01% 5410
2018
Q3
$22K Buy
6,115
+5,419
+779% +$19.5K ﹤0.01% 5028
2018
Q2
$2K Buy
+696
New +$2K ﹤0.01% 5725
2018
Q1
Sell
-894
Closed -$3K 6186
2017
Q4
$3K Sell
894
-10,862
-92% -$36.5K ﹤0.01% 5473
2017
Q3
$53K Buy
11,756
+10,923
+1,311% +$49.2K ﹤0.01% 4644
2017
Q2
$4K Sell
833
-4,376
-84% -$21K ﹤0.01% 5395
2017
Q1
$22K Sell
5,209
-40,567
-89% -$171K ﹤0.01% 4906
2016
Q4
$189K Buy
45,776
+7,262
+19% +$30K ﹤0.01% 3798
2016
Q3
$312K Sell
38,514
-12,867
-25% -$104K ﹤0.01% 3407
2016
Q2
$400K Sell
51,381
-13,004
-20% -$101K ﹤0.01% 3245
2016
Q1
$497K Buy
64,385
+11,717
+22% +$90.4K ﹤0.01% 3064
2015
Q4
$568K Buy
52,668
+46,063
+697% +$497K ﹤0.01% 3026
2015
Q3
$46K Buy
6,605
+5,555
+529% +$38.7K ﹤0.01% 4595
2015
Q2
$9K Sell
1,050
-2,865
-73% -$24.6K ﹤0.01% 5604
2015
Q1
$38K Sell
3,915
-11,685
-75% -$113K ﹤0.01% 4651
2014
Q4
$192K Sell
15,600
-15,600
-50% -$192K ﹤0.01% 3823
2014
Q3
$311K Buy
31,200
+29,200
+1,460% +$291K ﹤0.01% 3361
2014
Q2
$15K Sell
2,000
-21,607
-92% -$162K ﹤0.01% 4792
2014
Q1
$77K Sell
23,607
-5,000
-17% -$16.3K ﹤0.01% 4158
2013
Q4
$95K Sell
28,607
-11,813
-29% -$39.2K ﹤0.01% 4008
2013
Q3
$122K Buy
40,420
+33,620
+494% +$101K ﹤0.01% 3824
2013
Q2
$56K Buy
+6,800
New +$56K ﹤0.01% 4026